BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 33506633)

  • 1. Resident vs nonresident multipotent mesenchymal stromal cell interactions with B lymphocytes result in disparate outcomes.
    Lee W; Wang LT; Yen ML; Hsu PJ; Lee YW; Liu KJ; Lin KI; Su YW; Sytwu HK; Yen BL
    Stem Cells Transl Med; 2021 May; 10(5):711-724. PubMed ID: 33506633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts.
    Melief SM; Zwaginga JJ; Fibbe WE; Roelofs H
    Stem Cells Transl Med; 2013 Jun; 2(6):455-63. PubMed ID: 23694810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulatory effect of human bone marrow-derived mesenchymal stromal/stem cells on peripheral blood T cells from rheumatoid arthritis patients.
    Pedrosa M; Gomes J; Laranjeira P; Duarte C; Pedreiro S; Antunes B; Ribeiro T; Santos F; Martinho A; Fardilha M; Domingues MR; Abecasis M; P da Silva JA; Paiva A
    J Tissue Eng Regen Med; 2020 Jan; 14(1):16-28. PubMed ID: 31502378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone Marrow Mesenchymal Stromal Cells Induce Proliferative, Cytokinic and Molecular Changes During the T Cell Response: The Importance of the IL-10/CD210 Axis.
    Najar M; Raicevic G; Fayyad-Kazan H; De Bruyn C; Bron D; Toungouz M; Lagneaux L
    Stem Cell Rev Rep; 2015 Jun; 11(3):442-52. PubMed ID: 25326368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of the immunomodulatory capacities of human bone marrow- and adipose tissue-derived mesenchymal stromal cells from the same donor.
    Valencia J; Blanco B; Yáñez R; Vázquez M; Herrero Sánchez C; Fernández-García M; Rodríguez Serrano C; Pescador D; Blanco JF; Hernando-Rodríguez M; Sánchez-Guijo F; Lamana ML; Segovia JC; Vicente Á; Del Cañizo C; Zapata AG
    Cytotherapy; 2016 Oct; 18(10):1297-311. PubMed ID: 27637760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of Mesenchymal Stem Cells from Human Induced Pluripotent Stem Cells Results in Downregulation of c-Myc and DNA Replication Pathways with Immunomodulation Toward CD4 and CD8 Cells.
    Wang LT; Jiang SS; Ting CH; Hsu PJ; Chang CC; Sytwu HK; Liu KJ; Yen BL
    Stem Cells; 2018 Jun; 36(6):903-914. PubMed ID: 29396902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined use of bone marrow-derived mesenchymal stromal cells (BM-MSCs) and platelet rich plasma (PRP) stimulates proliferation and differentiation of myoblasts in vitro: new therapeutic perspectives for skeletal muscle repair/regeneration.
    Sassoli C; Vallone L; Tani A; Chellini F; Nosi D; Zecchi-Orlandini S
    Cell Tissue Res; 2018 Jun; 372(3):549-570. PubMed ID: 29404727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cells from human bone marrow or adipose tissue differently modulate mitogen-stimulated B-cell immunoglobulin production in vitro.
    Bochev I; Elmadjian G; Kyurkchiev D; Tzvetanov L; Altankova I; Tivchev P; Kyurkchiev S
    Cell Biol Int; 2008 Apr; 32(4):384-93. PubMed ID: 18262807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of immune modulatory properties of human multipotent mesenchymal stromal cells derived from bone marrow and placenta.
    Sarıkaya A; Aydın G; Özyüncü Ö; Şahin E; Uçkan-Çetinkaya D; Aerts-Kaya F
    Biotech Histochem; 2022 Feb; 97(2):79-89. PubMed ID: 33641543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Mesenchymal Stromal Cells From Different Origins for the Treatment of Graft-vs.-Host-Disease in a Humanized Mouse Model.
    Grégoire C; Ritacco C; Hannon M; Seidel L; Delens L; Belle L; Dubois S; Vériter S; Lechanteur C; Briquet A; Servais S; Ehx G; Beguin Y; Baron F
    Front Immunol; 2019; 10():619. PubMed ID: 31001253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive characterization of four different populations of human mesenchymal stem cells as regards their immune properties, proliferation and differentiation.
    Li X; Bai J; Ji X; Li R; Xuan Y; Wang Y
    Int J Mol Med; 2014 Sep; 34(3):695-704. PubMed ID: 24970492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoregulatory effects on T lymphocytes by human mesenchymal stromal cells isolated from bone marrow, amniotic fluid, and placenta.
    Mareschi K; Castiglia S; Sanavio F; Rustichelli D; Muraro M; Defedele D; Bergallo M; Fagioli F
    Exp Hematol; 2016 Feb; 44(2):138-150.e1. PubMed ID: 26577566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multipotent mesenchymal stromal cells in kidney transplant recipients: The next big thing?
    Sergeant E; Buysse M; Devos T; Sprangers B
    Blood Rev; 2021 Jan; 45():100718. PubMed ID: 32507576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic administration of bone marrow-derived mesenchymal stromal cells reduces airway inflammation without up-regulating Tregs in experimental asthma.
    Kitoko JZ; de Castro LL; Nascimento AP; Abreu SC; Cruz FF; Arantes AC; Xisto DG; Martins MA; Morales MM; Rocco PRM; Olsen PC
    Clin Exp Allergy; 2018 Feb; 48(2):205-216. PubMed ID: 29068567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptomic portrait of human Mesenchymal Stromal/Stem Cells isolated from bone marrow and placenta.
    Roson-Burgo B; Sanchez-Guijo F; Del Cañizo C; De Las Rivas J
    BMC Genomics; 2014 Oct; 15(1):910. PubMed ID: 25326687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory B Cells Contribute to the Clinical Response After Bone Marrow-Derived Mesenchymal Stromal Cell Infusion in Patients With Systemic Sclerosis.
    Loisel S; Lansiaux P; Rossille D; Ménard C; Dulong J; Monvoisin C; Bescher N; Bézier I; Latour M; Cras A; Farge D; Tarte K
    Stem Cells Transl Med; 2023 Apr; 12(4):194-206. PubMed ID: 36928395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells.
    Luz-Crawford P; Kurte M; Bravo-Alegría J; Contreras R; Nova-Lamperti E; Tejedor G; Noël D; Jorgensen C; Figueroa F; Djouad F; Carrión F
    Stem Cell Res Ther; 2013 Jun; 4(3):65. PubMed ID: 23734780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-γ-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus.
    Schena F; Gambini C; Gregorio A; Mosconi M; Reverberi D; Gattorno M; Casazza S; Uccelli A; Moretta L; Martini A; Traggiai E
    Arthritis Rheum; 2010 Sep; 62(9):2776-86. PubMed ID: 20496367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adeno-Associated Virus-Mediated Overexpression of Interleukin-10 Affects the Immunomodulatory Properties of Equine Bone Marrow-Derived Mesenchymal Stem Cells.
    Cameron AD; Even KM; Linardi RL; Berglund AK; Schnabel LV; Engiles JB; Ortved KF
    Hum Gene Ther; 2021 Sep; 32(17-18):907-918. PubMed ID: 33843261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of continuous passage on the immunomodulatory properties of equine bone marrow-derived mesenchymal stem cells in vitro.
    Connard SS; Linardi RL; Even KM; Berglund AK; Schnabel LV; Ortved KF
    Vet Immunol Immunopathol; 2021 Apr; 234():110203. PubMed ID: 33636546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.